Exome sequencing in a clinical laboratory

Jane Juusola, Ph.D., FACMG, Director, GeneDx Clinical Genomics Program

At the end of the session, the participants will be able to:
• Summarize the approach taken to analyze and interpret clinical exome data
• Describe the evolution of genes from candidate to disease-causing
• Identify why reanalyzing exome data is important

 

Question Title

* 1. Please rate the Session by circling the appropriate number:
Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree

  1 2 3 4 5
Sufficient time was allowed for audience participation/active learning
The facilities were satisfactory.
The session was free from commercial bias
Overall, I would rate this Symposium as excellent

Question Title

* 2. Please asses the Speakers by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Jane Juusola, Ph.D., FACMG, Director, GeneDx Clinical Genomics Program

  1 2 3 4 5
Clarity of
Met Stated Objectives
Balanced & Unbiased
Relevant to Practice Overall
Time for Active Learning

Question Title

* 3. As a result of attending this session, I am planning to: (please check one)

  YES NO
a) Discuss the session with my colleagues
b) Pursue additional learning activities.
c) Complete a Personal Learning Project.
d) Not change my practice.
e) Change my practice.

Question Title

* 4. Please explain the change you are planning to make or the learning you plan to complete:

Question Title

* 5. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

Question Title

* 6. General comments about individual speakers

Question Title

* 7. What topics need to be addressed at future conferences to keep you up to date in your profession?

T